The federal government has bankrolled the use of an artificial ketamine nasal spray to combat treatment-resistant depression, ...

An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making ...

Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression (TRD) too high to offer value for money, says a US cost-effectiveness body.

Johnson & Johnson's Spravato therapy for treatment ... "This provides further evidence for the use of esketamine nasal spray in this difficult-to-treat population and offers hope for the millions ...

With allergy season in full swing, Dr. Purvi Parikh joins Saturday TODAY to break down why many may be experiencing worse ...

The drug is provided as a single-use nasal spray. This application means it's absorbed directly through the nasal lining into the brain, so it starts to work within minutes. Spravato must also be ...

A nasal spray that uses a form of ketamine to treat stubborn depression will be added to the PBS, making treatment cheaper for thousands of Australians. It is the first new depression medication ...

Image: iStock Esketamine nasal spray will soon be subsidised under the Pharmaceutical Benefits Scheme (PBS), making it more affordable for eligible patients starting from May 1. It is the first ...